Govt Job: For Ph.D, M.Pharm, M.Sc as Research Associate at AIIMS

All-India Institute of Medical Sciences (AIIMS) was established as an institution of national importance by an Act of Parliament with the object of developing patterns of teaching in undergraduate and postgraduate medical education in all its branches so as to demonstrate a high standard of medical education in India; bringing together in one place educational facilities of the highest order for the training of personnel in all important branches of health activity, and attaining self-sufficiency in postgraduate medical education. 

The institute has comprehensive facilities for teaching, research, and patient care. As provided in the Act, AIIMS conducts teaching programs in medical and para-medical courses both at undergraduate and postgraduate levels and awards its own degrees.

Post : Research Associate – I

Project Title: “A randomized, open-label, parallel-group study to evaluate the safety and efficacy of abrocitinib 100 mg and 200 mg tablets in participants aged 12 years and older with moderate to severe atopic dermatitis in India,” funded by Pfizer.

Project code : N2272
Duration of project : 2 years

Emoluments : As per ICMR guidelines
Place of work : Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi.

Qualifications
i.  Ph.D / MD / MS / MDS OR
ii. MVSc / M.Pharm/ ME / M.Tech having 3 years of research experience with at least one publication in SCI journal

Age Limit : 40 years

Note
1. Only shortlisted candidates will be called for an interview. No TA/DA will be provided.

2. Send your CV with supporting documents in a single PDF file by email at dermatology.aiims12@adarsh

3. Please mention “Application for Research Associate-I in the subject line of the email.

Last date of receiving applications: July 17, till 5 PM.

Related Posts

WHO launches new primary health care course to strengthen health systems globally

Health is a human right – yet not everyone can access the health services they need, when and where they need them, without financial hardship. Primary health care (PHC) provides…

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Bengaluru: The Central Council for Research in Ayurvedic Sciences (CCRAS) has called for stronger scientific evidence, safety monitoring and translation of research into market-ready technologies to improve the credibility and…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

WHO launches new primary health care course to strengthen health systems globally

WHO launches new primary health care course to strengthen health systems globally

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert